Molecular Templates, Inc. (MTEM)
Largest Insider Buys in Sector
MTEM Stock Price History Chart
MTEM Stock Performance
About Molecular Templates, Inc.
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Insider Activity of Molecular Templates, Inc.
Over the last 12 months, insiders at Molecular Templates, Inc. have bought $2.59M and sold $0 worth of Molecular Templates, Inc. stock.
On average, over the past 5 years, insiders at Molecular Templates, Inc. have bought $18.79M and sold $7.66M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BIOTECH TARGET N V (10 percent owner) — $10.35M.
The last purchase of 250,000 shares for transaction amount of $587,500 was made by BIOTECH TARGET N V (10 percent owner) on 2024‑04‑02.
List of Insider Buy and Sell Transactions, Molecular Templates, Inc.
| 2024-04-02 | BIOTECH TARGET N V | 10 percent owner | 250,000 5.7535% | $2.35 | $587,500 | -22.37% | ||
| 2023-07-17 | BIOTECH TARGET N V | 10 percent owner | 4.26M 6.4706% | $0.47 | $2M | -53.58% | ||
| 2022-06-16 | McLennan Sean | See remarks | 30,000 0.0536% | $0.82 | $24,477 | -34.57% | ||
| 2022-06-13 | SANTE HEALTH VENTURES I LP | 62,000 0.1065% | $0.89 | $55,180 | -42.39% | |||
| 2022-06-13 | LALANDE KEVIN M. | 62,000 0.1065% | $0.89 | $55,180 | -42.39% | |||
| 2022-05-16 | BB BIOTECH AG | 200,000 0.3584% | $1.18 | $236,200 | -49.57% | |||
| 2022-01-06 | BIOTECH TARGET N V | 10 percent owner | 200,000 0.3471% | $4.04 | $807,180 | -77.97% | ||
| 2021-09-21 | BIOTECH TARGET N V | 10 percent owner | 750,000 1.2249% | $6.00 | $4.5M | -61.39% | ||
| 2021-09-16 | BIOTECH TARGET N V | 10 percent owner | 100,000 0.176% | $6.13 | $613,000 | -58.39% | ||
| 2021-07-27 | BIOTECH TARGET N V | 10 percent owner | 75,000 0.1333% | $7.09 | $531,840 | -52.96% | ||
| 2021-07-26 | BIOTECH TARGET N V | 10 percent owner | 80,000 0.141% | $7.00 | $559,816 | -52.55% | ||
| 2021-07-20 | BIOTECH TARGET N V | 10 percent owner | 125,000 0.2177% | $7.13 | $891,675 | -52.88% | ||
| 2021-07-19 | BIOTECH TARGET N V | 10 percent owner | 119,382 0.2095% | $6.96 | $830,827 | -51.20% | ||
| 2021-06-28 | Sale | Kim Jason S. | See remarks | 2,770 0.0049% | $8.36 | $23,157 | -54.01% | |
| 2021-04-19 | BIOTECH TARGET N V | 10 percent owner | 40,852 0.0709% | $8.08 | $329,941 | -27.38% | ||
| 2021-04-15 | BIOTECH TARGET N V | 10 percent owner | 150,000 0.2646% | $8.62 | $1.29M | -30.65% | ||
| 2021-04-14 | BIOTECH TARGET N V | 10 percent owner | 150,000 0.2714% | $8.37 | $1.26M | -26.73% | ||
| 2021-04-13 | BIOTECH TARGET N V | 10 percent owner | 100,000 0.1769% | $7.81 | $780,970 | -23.00% | ||
| 2021-04-12 | BIOTECH TARGET N V | 10 percent owner | 50,000 0.0914% | $8.02 | $400,830 | -22.31% | ||
| 2021-04-09 | BIOTECH TARGET N V | 10 percent owner | 235,664 0.4201% | $8.23 | $1.94M | -25.64% |
Insider Historical Profitability
| BIOTECH TARGET N V | 10 percent owner | 1279820 287.4311% | $1.08 | 32 | 0 | <0.0001% |
| BB BIOTECH AG | 11192003 208.2516% | $1.08 | 1 | 0 | <0.0001% | |
| SHV Management Services, LLC | 10 percent owner | 6097298 113.4535% | $1.08 | 0 | 2 | |
| Dyckerhoff Stefan A | 10 percent owner | 4715398 87.7403% | $1.08 | 0 | 3 | |
| Pullara Samuel J III | 10 percent owner | 4715398 87.7403% | $1.08 | 0 | 3 | |
| SUTTER HILL VENTURES | 10 percent owner | 4715398 87.7403% | $1.08 | 2 | 2 | |
| Hirsch David | 4199035 78.1322% | $1.08 | 2 | 0 | +10.35% | |
| BIRD JEFFREY W | director | 3940573 73.3229% | $1.08 | 3 | 3 | +58.99% |
| HealthCare Ventures VIII, L.P. | 10 percent owner | 3041268 56.5894% | $1.08 | 1 | 0 | |
| THREE ARCH MANAGEMENT III LLC | 10 percent owner | 2440202 45.4053% | $1.08 | 1 | 1 | |
| Christoffersen Ralph E | 2309382 42.9711% | $1.08 | 1 | 1 | ||
| MORGENTHALER PARTNERS VII LP | 10 percent owner | 2272345 42.2819% | $1.08 | 0 | 1 | |
| Morenstein Scott D | director | 2052991 38.2004% | $1.08 | 2 | 0 | +17.5% |
| CDK ASSOCIATES, L.L.C. | director | 1584241 29.4783% | $1.08 | 1 | 0 | +81.32% |
| ALTA BIOPHARMA PARTNERS III LP | 1439921 26.7929% | $1.08 | 1 | 0 | ||
| TANG KEVIN C | 10 percent owner | 1399877 26.0478% | $1.08 | 1 | 0 | |
| TIDMARSH GEORGE F | Founder and President | 992219 18.4624% | $1.08 | 2 | 0 | |
| SELICK HAROLD E | Chief Executive Officer | 372321 6.9278% | $1.08 | 7 | 0 | |
| WHITE JAMES N | 10 percent owner | 264669 4.9247% | $1.08 | 2 | 3 | |
| LALANDE KEVIN M. | 222000 4.1308% | $1.08 | 1 | 2 | <0.0001% | |
| SANTE HEALTH VENTURES I LP | 222000 4.1308% | $1.08 | 1 | 0 | <0.0001% | |
| COXE TENCH | 10 percent owner | 182828 3.4019% | $1.08 | 2 | 3 | |
| PROQUEST ASSOCIATES II LLC | 10 percent owner | 136417 2.5383% | $1.08 | 0 | 1 | |
| Curd John G | President and CMO | 127841 2.3788% | $1.08 | 19 | 0 | |
| SANDS GREGORY P | 10 percent owner | 90583 1.6855% | $1.08 | 2 | 0 | |
| YOUNGER WILLIAM H JR | 10 percent owner | 89275 1.6612% | $1.08 | 2 | 3 | |
| Kim Jason S. | See remarks | 83404 1.5519% | $1.08 | 0 | 1 | |
| JAEGER WILFRED E | director | 80000 1.4886% | $1.08 | 3 | 23 | |
| SHEEHAN ANDREW T | 10 percent owner | 78165 1.4544% | $1.08 | 2 | 3 | |
| BAKER G LEONARD JR | 10 percent owner | 74610 1.3883% | $1.08 | 2 | 3 | |
| GAITHER JAMES C | 10 percent owner | 49601 0.9229% | $1.08 | 2 | 3 | |
| McLennan Sean | See remarks | 30000 0.5582% | $1.08 | 1 | 0 | <0.0001% |
| Fernandes Joel A | Senior Vice President | 28120 0.5232% | $1.08 | 2 | 1 | |
| ANDERSON DAVID L | 10 percent owner | 15891 0.2957% | $1.08 | 2 | 3 | |
| POWELL MICHAEL | director | 12846 0.239% | $1.08 | 2 | 1 | |
| Speiser Michael L | 10 percent owner | 11884 0.2211% | $1.08 | 0 | 3 | |
| SWEET DAVID E | 10 percent owner | 11312 0.2105% | $1.08 | 2 | 3 | |
| PARKER GEORGE GC | director | 6072 0.113% | $1.08 | 0 | 1 | |
| Davar Nipun | Vice President | 3000 0.0558% | $1.08 | 1 | 0 | +35.88% |
| Pearce Tillman | Chief Medical Officer | 0 0% | $1.08 | 0 | 1 | |
| Frazier Healthcare VI, L.P. | 10 percent owner | 0 0% | $1.08 | 1 | 2 | |
| PEQUOT CAPITAL MANAGEMENT INC | 0 0% | $1.08 | 1 | 3 | ||
| Longitude Capital Partners III, LLC | 10 percent owner | 0 0% | $1.08 | 2 | 1 | +10.35% |
| SUTTER HILL ENTREPRENEURS FUND AI LP | 10 percent owner | 0 0% | $1.08 | 0 | 1 | |
| SUTTER HILL ENTREPRENEURS FUND QP LP | 10 percent owner | 0 0% | $1.08 | 0 | 1 |
Institutional Investor Ownership
No records found… | |||||||